Page last updated: 2024-08-25

chitosan and pulmicort

chitosan has been researched along with pulmicort in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, H; Nie, SF; Pan, WS; Tang, R; Wei, LL; Yang, XG; Zhou, LL1
Glavas Dodov, M; Goracinova, K; Simonoska Crcarevska, M1
Crcarevska, MS; Dodov, MG; Gjorgoski, I; Goracinova, K; Petrusevska, G1
Jain, S; Kaur, G; Rana, V; Tiwary, AK1
Liang, ZL; Mao, SR; Muenster, U; Ni, R; Wang, XH; Zhang, L1
Akrivou, M; Bouropoulos, N; Eleftheriadis, GK; Fatouros, DG; Tsibouklis, J; Vizirianakis, IS1
Beck-Broichsitter, M; Fan, L; Jiaqi, L; Mao, S; Muenster, U; Wang, X; Yang, L; Zhang, L; Zhang, X; Zhang, Y; Zhao, J1
Bodas, DS; Ige, PP1
Campos, JC; Costa, PJ; Ferreira, DC; Lima, S; Reis, S1

Other Studies

9 other study(ies) available for chitosan and pulmicort

ArticleYear
Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    International journal of pharmaceutics, 2007, Mar-06, Volume: 332, Issue:1-2

    Topics: Animals; Anti-Inflammatory Agents; Bacteria; Budesonide; Cellulose; Chemistry, Pharmaceutical; Chitosan; Citric Acid; Colon; Drug Carriers; Drug Compounding; Excipients; Gels; In Vitro Techniques; Kinetics; Male; Membranes, Artificial; Models, Chemical; Osmotic Pressure; Permeability; Porosity; Rats; Rats, Wistar; Solubility; Tablets, Enteric-Coated; Viscosity

2007
Chitosan coated Ca-alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2008, Volume: 68, Issue:3

    Topics: Alginates; Budesonide; Calorimetry; Chitosan; Colitis; Drug Delivery Systems; Drug Stability; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogen-Ion Concentration; Particle Size; Solubility; Thermogravimetry; X-Ray Diffraction

2008
Bioefficacy of budesonide loaded crosslinked polyelectrolyte microparticles in rat model of induced colitis.
    Journal of drug targeting, 2009, Volume: 17, Issue:10

    Topics: Alginates; Animals; Anti-Inflammatory Agents; Budesonide; Calcium Chloride; Chitosan; Colitis; Cross-Linking Reagents; Delayed-Action Preparations; Disease Models, Animal; Drug Delivery Systems; Electrolytes; Glucuronic Acid; Hexuronic Acids; Male; Microspheres; Polymethacrylic Acids; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid

2009
Colon delivery of budesonide: evaluation of chitosan-chondroitin sulfate interpolymer complex.
    AAPS PharmSciTech, 2010, Volume: 11, Issue:1

    Topics: Acrylic Resins; Animals; Budesonide; Chitosan; Chondroitin; Chondroitin Sulfates; Colon; Excipients; Female; Male; Rats; Rats, Sprague-Dawley; Tablets; Water

2010
[Preparation of budesonide sustained-release dry powder for inhalation and influence of lactose content].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2015, Volume: 50, Issue:9

    Topics: Administration, Inhalation; Budesonide; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Drug Carriers; Lactose; Particle Size; Powders

2015
Polymer-Lipid Microparticles for Pulmonary Delivery.
    Langmuir : the ACS journal of surfaces and colloids, 2018, 03-20, Volume: 34, Issue:11

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Budesonide; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Compounding; Drug Liberation; Excipients; Female; Humans; Lactose; Leucine; Male; Mucus; Particle Size; Polyvinyl Alcohol; Pulmonary Surfactants

2018
Sustained therapeutic efficacy of budesonide-loaded chitosan swellable microparticles after lung delivery: Influence of in vitro release, treatment interval and dose.
    Journal of controlled release : official journal of the Controlled Release Society, 2018, 08-10, Volume: 283

    Topics: Administration, Inhalation; Animals; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Budesonide; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Liberation; Female; Interleukin-4; Interleukin-5; Lung; Mice, Inbred BALB C; Microspheres; Rats

2018
Central composite rotatable design for optimization of budesonide-loaded cross-linked chitosan-dextran sulfate nanodispersion: characterization,
    Drug development and industrial pharmacy, 2019, Volume: 45, Issue:7

    Topics: Budesonide; Chitosan; Dextran Sulfate; Drug Carriers; Drug Liberation; Nanoparticles; Particle Size; Solubility

2019
Swellable polymeric particles for the local delivery of budesonide in oral mucositis.
    International journal of pharmaceutics, 2019, Jul-20, Volume: 566

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Budesonide; Cell Line; Chitosan; Drug Delivery Systems; Drug Liberation; Humans; Particle Size; Polymers; Polymethacrylic Acids; Stomatitis

2019